N
GH icon

Natixis’s Guardant Health GH Stock Holding History

Natixis’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,250
Closed -$230K – 1194
2025
Q4 		$230K Sell
2,250
-55,650
-96% -$4.98M ﹤0.01% 920
2025
Q3 		$3.62M Buy
+57,900
New +$3.15M 0.02% 486
2024
Q3 		– Sell
-1
Closed -$29 – 1022
2024
Q2 		$29 Hold
1
– – ﹤0.01% 969
2024
Q1 		$21 Sell
1
-15,926
-100% -$341K ﹤0.01% 989
2023
Q4 		$431K Buy
+15,927
New +$418K ﹤0.01% 638
2023
Q3 		– Sell
-22,837
Closed -$818K – 1044
2023
Q2 		$818K Buy
+22,837
New +$656K 0.01% 578
2022
Q4 		– Sell
-24,503
Closed -$1.35M – 1195
2022
Q3 		$1.35M Sell
24,503
-37,118
-60% -$1.91M 0.01% 694
2022
Q2 		$2.49M Buy
61,621
+26,334
+75% +$1.3M 0.01% 617
2022
Q1 		$2.34M Sell
35,287
-28,953
-45% -$1.98M 0.01% 720
2021
Q4 		$6.42M Buy
64,240
+25,605
+66% +$2.65M 0.02% 501
2021
Q3 		$4.83M Sell
38,635
-11,973
-24% -$1.42M 0.02% 548
2021
Q2 		$6.29M Buy
50,608
+6,228
+14% +$838K 0.03% 343
2021
Q1 		$6.78M Sell
44,380
-9,681
-18% -$1.46M 0.02% 452
2020
Q4 		$6.97M Buy
54,061
+3,606
+7% +$415K 0.03% 459
2020
Q3 		$5.64M Sell
50,455
-7,154
-12% -$654K 0.04% 253
2020
Q2 		$4.67M Buy
+57,609
New +$4.64M 0.04% 303
2019
Q4 		– Sell
-392,765
Closed -$25.1M – 879
2019
Q3 		$25.1M Buy
392,765
+374,813
+2,088% +$33M 0.16% 134
2019
Q2 		$1.55M Sell
17,952
-65,713
-79% -$5.02M 0.01% 477
2019
Q1 		$6.17M Buy
+83,665
New +$4.64M 0.04% 350

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Natixis's GH Position: Q1 2026 in Review

Natixis sold out of Guardant Health (GH) in Q1 2026, closing a stake of 2,250 shares — an estimated $230K sold.

Natixis first reported a position in GH in Q1 2019 and held it in 19 quarters. The position peaked at $25.1M in Q3 2019. 484 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Natixis reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Natixis sold 2,250 Guardant Health shares in Q1 2026, an estimated $230K.
  • Natixis first reported a position in Guardant Health in Q1 2019 and held it in 19 quarters.
  • Natixis's Guardant Health position peaked at $25.1M in Q3 2019.
  • 484 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.